2017
DOI: 10.3389/fbioe.2017.00023
|View full text |Cite
|
Sign up to set email alerts
|

Recent Advances in Bioink Design for 3D Bioprinting of Tissues and Organs

Abstract: There is a growing demand for alternative fabrication approaches to develop tissues and organs as conventional techniques are not capable of fabricating constructs with required structural, mechanical, and biological complexity. 3D bioprinting offers great potential to fabricate highly complex constructs with precise control of structure, mechanics, and biological matter [i.e., cells and extracellular matrix (ECM) components]. 3D bioprinting is an additive manufacturing approach that utilizes a “bioink” to fab… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
271
0
4

Year Published

2018
2018
2024
2024

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 379 publications
(277 citation statements)
references
References 91 publications
2
271
0
4
Order By: Relevance
“…138,140,141 However, the low resolution of available bioprinters and methods for bioprinting the vasculature (such as sacrificial hydrogel) make it impossible to print hepatic tissue with an integrated and perfusable vascular network with complex branching in a range of diameters from large vessels to capillaries. 142,143 The same holds true for the periportal to pericentral zonal distrubition. 142,143 The technology to transcend these challenges might be years away, but the potential of these biofabrication techniques is clear and compelling when considering whole-liver bioengineering.…”
Section: Future Directionsmentioning
confidence: 74%
See 1 more Smart Citation
“…138,140,141 However, the low resolution of available bioprinters and methods for bioprinting the vasculature (such as sacrificial hydrogel) make it impossible to print hepatic tissue with an integrated and perfusable vascular network with complex branching in a range of diameters from large vessels to capillaries. 142,143 The same holds true for the periportal to pericentral zonal distrubition. 142,143 The technology to transcend these challenges might be years away, but the potential of these biofabrication techniques is clear and compelling when considering whole-liver bioengineering.…”
Section: Future Directionsmentioning
confidence: 74%
“…142,143 The same holds true for the periportal to pericentral zonal distrubition. 142,143 The technology to transcend these challenges might be years away, but the potential of these biofabrication techniques is clear and compelling when considering whole-liver bioengineering. They allow not only the generation of organs on demand, but also a more exact and rapid 3D recreation of hepatic tissue with all of its refinements, and are only limited by our knowledge of what and where to print.…”
Section: Future Directionsmentioning
confidence: 74%
“…Fused deposition modelling (FDM) is an example of extrusion‐based printing used for synthetic thermoplastics and their composites. The technique is unsuitable for bioprinting as it involves melting thermoplastics at very high temperatures (Ji & Guvendiren, ). Therefore, a slightly modified FDM‐based printer has been developed by our group at the University of Bridgeport (Halim et al, ).…”
Section: D Bioprinting Technologiesmentioning
confidence: 99%
“…Inspite of the different printing methods used, there is a certain set of characteristics that need to be achieved in terms of both material (printability, flowability, and degradability) as well as biological (cytocompatibility and differentiation) requirements for appropriate ink preparation (Ji & Guvendiren, ). Different biocompatible materials ranging from naturally derived to chemically synthesized polymers, ceramics, bioactive glasses, and their modified derivatives are being extensively investigated as potential bioinks for bone.…”
Section: Bioinkmentioning
confidence: 99%
“…To address this, dECM would be a suitable bioink as it is an excellent candidate for providing cells with the signals required to induce and maintain differentiation into tissue‐specific lineages (Agmon & Christman, ). Decellularized tissue or ECM‐based bioink formulations are developing fields due to their ease of printability and their inherent bioactivity (Ji & Guvendiren, ). dECM from cartilage (Pati et al, ), fat (Pati et al, ), heart (Das & Jang, ), skin (Ahn et al, ), and liver (Lee et al, ) has already been used for 3D bioprinting.…”
Section: Future Prospectsmentioning
confidence: 99%